Buy or sell Kaspersky Lab stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
Kaspersky Lab Stock
Endpoint protection solutions for consumers, SMBs and enterprises.
About Kaspersky Lab Stock
Kaspersky Lab is the world’s largest privately held vendor of endpoint protection solutions. The company is ranked among the world’s top four vendors of security solutions for endpoint users. It is an innovator in IT security and provides effective digital security solutions and threat management systems for consumers, SMBs and enterprises. The Kaspersky anti-virus engine also powers products and solutions by other security vendors such as Check Point, Bluecoat, Juniper Networks, Sybari, Netintelligence, Clearswift, FrontBridge, Netasq, Wedge Networks, and others. Kaspersky Lab is headquartered in Moscow, Russia, with 30 regional offices in Australia, Austria, Benelux, Brazil, Canada, Mainland China, France, Germany, Hong Kong, India, Italy, Taiwan, Japan, Kazakhstan, Korea, Latvia, Malaysia, Poland, Portugal, Romania, Russian Federation, South Africa, Spain, Sweden, Switzerland, Turkey, Ukraine, United Arab Emirates, United Kingdom, and the United States of America. It was co-founded by Eugene Kaspersky and Natalia Kaspersky in 1997. Kaspersky Lab has over 2,500 employees, including more than 800 research and development specialists, providing protection for over 300 million users worldwide.
Funding History
January 2011 | $0 |
---|
Management
Enterprise & Partner Pre-Sales Engineer
Mark Olding
Research Development Team Lead
Victor Chebyshev
Head, Global Research and Analysis Team, Russia
Yury Namestnikov
Head, Global Product & Technology Intelligence
Vladimir Zapolyansky
Chief Legal Officer
Igor Chekunov
Head of Global Research & Analysis Team, USA
Ryan Naraine
Malware Aanalyst
Boris Larin
President, North America
Stephen Orenberg
Security Expert, Anti-Malware Research, USA
Mikhail Pavlyushchik
HEAD of Global Research and Analysis Team, LatAm
Dmitry Bestuzhev
Press
Forbes - Mar, 13 2020
Forbes - Nov, 12 2019
Forbes - Oct, 20 2019
Forbes - Oct, 4 2019
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase